BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1319, American Rescue Plan Act of 2021 - regarding all bio-pharmaceutical related provisions S 464/HR 2163, Safe Step Act - regarding all bio-pharmaceutical related provisions Proposed reconciliation bill encompassing all pharmaceutical provisions Discussions regarding health equity Issues regarding HR 6833, Continuing Resolution HR 5376, the Build Back Better Act regarding all bio-pharmaceutical provisions Discussions regarding HR 3173, Improving Seniors' Timely Access to Care Act PBM reform including S.4293, Pharmacy Benefit Manager Transparency Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| STEPHANIE A. DYSON | — |
| JEFFREY LAST | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| RICARDO SANCHEZ ORTEGON | — |
| PAUL ANTHONY WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions HR 5237, to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients/ out-of-pocket costs Issues related to the Inflation Reduction Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE A. DYSON | — |
| JEFFREY LAST | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| RICARDO SANCHEZ ORTEGON | — |
| CAROLINE TUCKER New | — |
| PAUL ANTHONY WILLIAMS | — |
Trade (domestic/foreign) TRD
Trade-Related Aspects of Intellectual Property (TRIPS) Waiver. No related bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEOUDES | — |
| JEFFREY LAST | — |
| LANE PENRY | — |
| RICARDO SANCHEZ ORTEGON | — |
| PAUL ANTHONY WILLIAMS | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEOUDES | — |
Budget/Appropriations BUD
Discussions regarding HR 2617, Consolidated Appropriations Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| PAUL ANTHONY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.